This is a Validated Antibody Database (VAD) review about dogs DLA-DRA, based on 109 published articles (read how Labome selects the articles), using DLA-DRA antibody in all methods. It is aimed to help Labome visitors find the most suited DLA-DRA antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
DLA-DRA synonym: DLA-DRA1

Invitrogen
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3c
Invitrogen DLA-DRA antibody (eBioscience, 11-9952-41) was used in flow cytometry on human samples (fig 3c). Cell (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3a
Invitrogen DLA-DRA antibody (eBioscience, L243) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; rhesus macaque; loading ...; fig 1a
In order to examine frequency and function of myeloid-derived suppressor cells in SIV-infected rhesus macaques, Invitrogen DLA-DRA antibody (Fisher Scientific, L243) was used in flow cytometry on rhesus macaque samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
In order to study the restoration of immune function in chronic HIV infection, Invitrogen DLA-DRA antibody (eBioscience, L240) was used in flow cytometry on human samples (fig 1a). J Clin Invest (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...
In order to establish the T Cell receptor-inducible costimulator as a promising target for direct T regulatory cell-targeting therapeutic agents for gastric cancer, Invitrogen DLA-DRA antibody (eBioscience, L243) was used in flow cytometry on human samples . Int J Cancer (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:50; fig s2c
In order to develop and characterize a humanized ossicle xenotransplantation approach, Invitrogen DLA-DRA antibody (ebioscience, L243) was used in flow cytometry on human samples at 1:50 (fig s2c). Nat Med (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:20; loading ...; fig s5j
In order to describe the role of mTOR signalling in recruiting pro-tumorigenic myeloid-derived suppressor cells., Invitrogen DLA-DRA antibody (eBioscience, 12-9952-41) was used in flow cytometry on human samples at 1:20 (fig s5j). Nat Cell Biol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig st1
In order to discuss the impact of filaggrin mutations on the development of atopic dermatitis, Invitrogen DLA-DRA antibody (eBiosciences, L243-ef450) was used in flow cytometry on human samples (fig st1). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
Invitrogen DLA-DRA antibody (eBioscience, 25-9952-41) was used in flow cytometry on human samples . Nanomedicine (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
Invitrogen DLA-DRA antibody (eBioscience, L243) was used in flow cytometry on human samples . J Hepatol (2014) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig S2
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen DLA-DRA antibody (eBioscience, 48-9952-42) was used in flow cytometry on human samples (fig S2). Proc Natl Acad Sci U S A (2012) ncbi
BD Biosciences
mouse monoclonal (TU36)
  • flow cytometry; human; fig 2b
BD Biosciences DLA-DRA antibody (BD Pharmingen, TU36) was used in flow cytometry on human samples (fig 2b). Oncoimmunology (2022) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig s3b
BD Biosciences DLA-DRA antibody (BD, G46-6) was used in flow cytometry on human samples (fig s3b). Front Immunol (2021) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; loading ...; fig 1f
BD Biosciences DLA-DRA antibody (BD Biosciences, 555561) was used in flow cytometry on human samples (fig 1f). Cell Res (2020) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 1a, 4b
BD Biosciences DLA-DRA antibody (BD, G46-6) was used in flow cytometry on human samples (fig 1a, 4b). Rheumatology (Oxford) (2020) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 5d
BD Biosciences DLA-DRA antibody (BD, 555812) was used in flow cytometry on human samples (fig 5d). Front Immunol (2019) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig s5c
BD Biosciences DLA-DRA antibody (BD, G46-6) was used in flow cytometry on human samples (fig s5c). PLoS Pathog (2019) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; mouse; loading ...
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on mouse samples . Nature (2019) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; rhesus macaque; loading ...; fig 2d
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on rhesus macaque samples (fig 2d). J Virol (2019) ncbi
monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences DLA-DRA antibody (BD, 564516) was used in flow cytometry on human samples (fig 2a). J Exp Med (2018) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 1d
BD Biosciences DLA-DRA antibody (BD PharMingen, 560943) was used in flow cytometry on human samples (fig 1d). J Exp Med (2018) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig s1a
In order to study the effect off HIV 1 vaccination in HIV carriers, BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig s1a). Front Immunol (2017) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 7
BD Biosciences DLA-DRA antibody (BD Bioscience, G46-6) was used in flow cytometry on human samples (fig 7). J Immunol (2017) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 5c
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 5c). J Immunol (2017) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 1c
In order to evaluate the role of IL-32alpha in NK cell inhibition, BD Biosciences DLA-DRA antibody (BD Biosciences, G46.6) was used in flow cytometry on human samples (fig 1c). J Immunol (2017) ncbi
mouse monoclonal (G46-6)
  • other; human; fig s1
In order to investigate the mechanisms of toxicity by the negative allosteric modulators of metabotropic glutamate receptor 5, BD Biosciences DLA-DRA antibody (BD/Pharm, 555809) was used in other on human samples (fig s1). Cell Chem Biol (2017) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 2b
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 2b). Sci Rep (2017) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; 1:500; loading ...; fig s1b
In order to study the antigen presentation by HLA-DP84Gly through the class I antigen processing pathway, BD Biosciences DLA-DRA antibody (BD Biosciences, 555561) was used in flow cytometry on human samples at 1:500 (fig s1b). Nat Commun (2017) ncbi
mouse monoclonal (G46-6)
  • blocking or activating experiments; human; 1 ug/ml; loading ...; fig 1e
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in blocking or activating experiments on human samples at 1 ug/ml (fig 1e). J Immunol (2017) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 3a
In order to compare methods of isolating skin mononuclear phagocytes, BD Biosciences DLA-DRA antibody (Becton Dickinson, G46-6) was used in flow cytometry on human samples (fig 3a). J Leukoc Biol (2017) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...
In order to test if TRAIL/TRAIL-R signaling in cancer cells alters the immune microenvironment, BD Biosciences DLA-DRA antibody (BD Bioscience, 556643) was used in flow cytometry on human samples . Mol Cell (2017) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig S1a
BD Biosciences DLA-DRA antibody (BD, 561224) was used in flow cytometry on human samples (fig S1a). Sci Rep (2017) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig s2
BD Biosciences DLA-DRA antibody (BD, G46-6) was used in flow cytometry on human samples (fig s2). Oncoimmunology (2017) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences DLA-DRA antibody (BD Pharmingen, G46-6) was used in flow cytometry on human samples (fig 1a). JCI Insight (2017) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 6e
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BD Biosciences DLA-DRA antibody (BD Bioscience, G46-6) was used in flow cytometry on human samples (fig 6e). Sci Rep (2017) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; loading ...; fig 4b
BD Biosciences DLA-DRA antibody (BD Biosciences, 555560) was used in flow cytometry on human samples (fig 4b). PLoS ONE (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences DLA-DRA antibody (BD, G46-6) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; tbl s2
BD Biosciences DLA-DRA antibody (BD Biosciences, 561224) was used in flow cytometry on human samples (tbl s2). Science (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; tbl 3
In order to optimize a method to generate granulocyte lineage-committed progenitors from umbilical cord blood samples, BD Biosciences DLA-DRA antibody (Becton Dickinson, G46-6) was used in flow cytometry on human samples (tbl 3). N Biotechnol (2017) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
In order to evaluate combinations of TLR and C-type lectin receptor agonists on the Th1 responses of newborn dendritic cells, BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . J Immunol (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; tbl 3
BD Biosciences DLA-DRA antibody (BD Pharmingen, G46-6) was used in flow cytometry on human samples (tbl 3). Brain Behav (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences DLA-DRA antibody (BD Biosciences, 560944) was used in flow cytometry on human samples (fig 1c). Mol Med Rep (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; rhesus macaque; loading ...; fig s11b
In order to assess the efficacy of targeting alpha4 beta7 integrin to treat SIV, BD Biosciences DLA-DRA antibody (BD Pharmingen, 552764) was used in flow cytometry on rhesus macaque samples (fig s11b). Science (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 4a
In order to characterize CD8 positive T cell subsets in dengue patients from India and Thailand, BD Biosciences DLA-DRA antibody (BD, 560896) was used in flow cytometry on human samples (fig 4a). J Virol (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 4b
In order to define the contribution of CD103+ tumor-infiltrating lymphocytes to high-grade serous epithelial ovarian cancer, BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 4b). Oncotarget (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 6a
BD Biosciences DLA-DRA antibody (Becton Dickinson, G46-6) was used in flow cytometry on human samples (fig 6a). J Virol (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
In order to investigate the impact of CD1c positive dendritic cells on immunogenic cell death, BD Biosciences DLA-DRA antibody (BD PharMingen, 555812) was used in flow cytometry on human samples . Oncoimmunology (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 3a
In order to identify cells that respond to interferon lambda, BD Biosciences DLA-DRA antibody (BD Bioscience, G46-6) was used in flow cytometry on human samples (fig 3a). J Interferon Cytokine Res (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; 1:1000
BD Biosciences DLA-DRA antibody (BD Biosciences, 560896) was used in flow cytometry on human samples at 1:1000. Oncol Lett (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig s1e
In order to compare expression and function of the CD300 family of receptors between neonatal and adult immune cells, BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig s1e). Sci Rep (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 1
BD Biosciences DLA-DRA antibody (BD Biosciences, 555812) was used in flow cytometry on human samples (fig 1). Mol Med Rep (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 1
BD Biosciences DLA-DRA antibody (BD Biosciences, 556644) was used in flow cytometry on human samples (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 2a). Eur J Immunol (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 1
In order to study activation of myeloid dendritic cells, regulatory T cells and effector cells in lichen planus, BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 1). J Transl Med (2016) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; loading ...; fig 2
In order to assess the ability of human cystatin C to alter pathogenic activated monocytes and modulate Crohn's disease, BD Biosciences DLA-DRA antibody (BD Pharmingen, TU36) was used in flow cytometry on human samples (fig 2). J Leukoc Biol (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; 1:200; loading ...; fig 7j
In order to find that coagulation factor XII modulates immune responses, BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples at 1:200 (fig 7j). Nat Commun (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; 1:100; fig 5
BD Biosciences DLA-DRA antibody (BD PharMingen, 561224) was used in flow cytometry on human samples at 1:100 (fig 5). Oncoimmunology (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 7a
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 7a). PLoS ONE (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; tbl 2
In order to assess the protective immunological events induced by vaccination with Leishmune in dogs, BD Biosciences DLA-DRA antibody (BD Biosciences, 559866) was used in flow cytometry on human samples (tbl 2). Vet Parasitol (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 1
BD Biosciences DLA-DRA antibody (BD Biosciences, 555811) was used in flow cytometry on human samples (fig 1). Int J Mol Med (2016) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences DLA-DRA antibody (BD, 555561) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; loading ...; fig 7c
BD Biosciences DLA-DRA antibody (BD Bioscience, TU36) was used in flow cytometry on human samples (fig 7c). PLoS ONE (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; 1:40; fig 2
BD Biosciences DLA-DRA antibody (BD Horizon, G46-6) was used in flow cytometry on human samples at 1:40 (fig 2). Nat Commun (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 5
BD Biosciences DLA-DRA antibody (BD Bioscience, G46-6) was used in flow cytometry on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig S1A
In order to analyze the frequency and phenotype of monocyte subpopulations in peripheral blood, cerebrospinal fluid, and brain biopsy material derived from multiple sclerosis patients, BD Biosciences DLA-DRA antibody (BD, G46-6) was used in flow cytometry on human samples (fig S1A). J Immunol (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences DLA-DRA antibody (BD Pharmingen, 560943) was used in flow cytometry on human samples (fig 2a). Mol Med Rep (2016) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences DLA-DRA antibody (BD Biosciences, TU36) was used in flow cytometry on human samples (fig 1c). Cytotherapy (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig s3
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig s3). Sci Transl Med (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; rhesus macaque
In order to characterize functional and phenotypic properties of monoclonal antibodies specific for Rhesus Macaque CD200, Mincle, and CD200R, BD Biosciences DLA-DRA antibody (BD, 552764) was used in flow cytometry on rhesus macaque samples . PLoS ONE (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 2i
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 2i). J Immunol (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; mouse; loading ...; fig s2d
In order to assess the effects of allosteric inhibitors on different mutant forms of isocitrate dehydrogenase 1 in leukemia, BD Biosciences DLA-DRA antibody (BD Pharmingen, G46-6) was used in flow cytometry on mouse samples (fig s2d). Nat Chem Biol (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig e4b
In order to discuss the importance of IL-5 positive Th2 cells to allergies, BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig e4b). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; cat; 1:50; tbl 3
BD Biosciences DLA-DRA antibody (BD Biosciences,, 555810) was used in flow cytometry on cat samples at 1:50 (tbl 3). Cell Reprogram (2015) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; tbl 1
BD Biosciences DLA-DRA antibody (BD bioscience, 555561) was used in flow cytometry on human samples (tbl 1). PLoS ONE (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 2
BD Biosciences DLA-DRA antibody (BD Biosciences, 561224) was used in flow cytometry on human samples (fig 2). J Endod (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 2
BD Biosciences DLA-DRA antibody (BD Biosciences, 555810) was used in flow cytometry on human samples (fig 2). Int J Mol Med (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
In order to generate three different polarized macrophage and assess their immune function in an air-blood barrier co-culture, BD Biosciences DLA-DRA antibody (BD Biosciences, 559866) was used in flow cytometry on human samples . J Tissue Eng Regen Med (2017) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to discuss the contribution of missense mutations in PDE3A to hypertension, BD Biosciences DLA-DRA antibody (BD Biosciences, 555561) was used in flow cytometry on human samples . Nat Genet (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 2
  • immunocytochemistry; human; fig 1
BD Biosciences DLA-DRA antibody (BD Pharmingen, G46-6) was used in flow cytometry on human samples (fig 2) and in immunocytochemistry on human samples (fig 1). Immunol Cell Biol (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; tbl s1
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 3
In order to study human cord blood and bone marrow for restricted dendritic cell and monocyte progenitors, BD Biosciences DLA-DRA antibody (BD, G46-6) was used in flow cytometry on human samples (fig 3). J Exp Med (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 2
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 2). J Autoimmun (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Pharmingen, G46-6) was used in flow cytometry on human samples . Clin Cancer Res (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Pharmingen, 559866) was used in flow cytometry on human samples . Alcohol (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . Immun Inflamm Dis (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; tbl 1
BD Biosciences DLA-DRA antibody (BD Biosciences, 555812) was used in flow cytometry on human samples (tbl 1). Exp Ther Med (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; 1:5
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples at 1:5. Nat Commun (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 2
BD Biosciences DLA-DRA antibody (Becton Dickinson, G46-6) was used in flow cytometry on human samples (fig 2). Blood (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; fig 4
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples (fig 4). Immunol Cell Biol (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (G46-6)
  • immunohistochemistry - paraffin section; human; 1:100
BD Biosciences DLA-DRA antibody (BD Biosciences, 555811) was used in immunohistochemistry - paraffin section on human samples at 1:100. Mol Med Rep (2015) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD, G46-6) was used in flow cytometry on human samples . PLoS Negl Trop Dis (2014) ncbi
mouse monoclonal (TU36)
  • immunocytochemistry; mouse
BD Biosciences DLA-DRA antibody (PharMingen, TU36) was used in immunocytochemistry on mouse samples . Hum Pathol (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (Becton Dickenson, G46-6) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . Clin Exp Allergy (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (G46-6)
  • immunoprecipitation; human
  • western blot; human
In order to demonstrate that CPXV012 inhibits peptide transport by inhibiting ATP binding to the transporter associated with antigen processing, BD Biosciences DLA-DRA antibody (BD Pharmingen, 347401) was used in immunoprecipitation on human samples and in western blot on human samples . J Immunol (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig s1b
BD Biosciences DLA-DRA antibody (BD Biosciences, 555812) was used in flow cytometry on human samples (fig s1b). Oncotarget (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
In order to investigate the effects of Nucleofection on freshly isolated primary CD4 T cell morphology, intracellular calcium levels, cell surface activation markers, and transcriptional activity, BD Biosciences DLA-DRA antibody (Becton Dickinson Pharmingen, 555811) was used in flow cytometry on human samples . J Immunol Methods (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Biosciences, G46) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
In order to develop methods to isolate inducible PMLC (HLA-DR(+)CD14(++)CD16(-) cells) and then characterize these cells, BD Biosciences DLA-DRA antibody (BD Horizon, 561359) was used in flow cytometry on human samples . J Inflamm (Lond) (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; chimpanzee
In order to study the in vitro response of gammadelta T-cell subsets from HIV1-infected and control chimpanzees to T-cell activators, BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6/L243) was used in flow cytometry on chimpanzee samples . J Med Primatol (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human
BD Biosciences DLA-DRA antibody (BD Biosciences, G46-6) was used in flow cytometry on human samples . Mol Immunol (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the importance of assessing immune competence in cancer patients, BD Biosciences DLA-DRA antibody (BD, G46-6) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; loading ...; fig 4B
In order to investigate human T lymphotropic virus type 1 bZIP factor-specific CD4 T cell responses, BD Biosciences DLA-DRA antibody (BD, G46-6) was used in flow cytometry on human samples (fig 4B). J Immunol (2014) ncbi
mouse monoclonal (G46-6)
  • flow cytometry; human; 1:5
BD Biosciences DLA-DRA antibody (BD Pharmingen, G46-6) was used in flow cytometry on human samples at 1:5. Microvasc Res (2012) ncbi
Articles Reviewed
  1. Kono M, Komatsuda H, Yamaki H, Kumai T, Hayashi R, Wakisaka R, et al. Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma. Oncoimmunology. 2022;11:2021619 pubmed publisher
  2. Reis M, Willis G, Fernandez Gonzalez A, Yeung V, Taglauer E, Magaletta M, et al. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Restore Thymic Architecture and T Cell Function Disrupted by Neonatal Hyperoxia. Front Immunol. 2021;12:640595 pubmed publisher
  3. Wu J, Song D, Li Z, Guo B, Xiao Y, Liu W, et al. Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis. Cell Res. 2020;30:794-809 pubmed publisher
  4. Kim J, Jeong J, Jung J, Jeon H, Lee S, Lim J, et al. Immunological characteristics and possible pathogenic role of urinary CD11c+ macrophages in lupus nephritis. Rheumatology (Oxford). 2020;: pubmed publisher
  5. Trus I, Udenze D, Bérubé N, Wheler C, Martel M, Gerdts V, et al. CpG-Recoding in Zika Virus Genome Causes Host-Age-Dependent Attenuation of Infection With Protection Against Lethal Heterologous Challenge in Mice. Front Immunol. 2019;10:3077 pubmed publisher
  6. Banga R, Rebecchini C, Procopio F, Noto A, Munoz O, Ioannidou K, et al. Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement. PLoS Pathog. 2019;15:e1007918 pubmed publisher
  7. Veglia F, Tyurin V, Blasi M, De Leo A, Kossenkov A, Donthireddy L, et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature. 2019;569:73-78 pubmed publisher
  8. Georgouli M, Herraiz C, Crosas Molist E, Fanshawe B, Maiques O, Perdrix A, et al. Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment. Cell. 2019;176:757-774.e23 pubmed publisher
  9. Chea L, Wyatt L, Gangadhara S, Moss B, Amara R. Novel Modified Vaccinia Virus Ankara Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses. J Virol. 2019;93: pubmed publisher
  10. Perciani C, Farah B, Kaul R, Ostrowski M, Mahmud S, Anzala O, et al. Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation. J Clin Invest. 2019;129:875-886 pubmed publisher
  11. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed publisher
  12. Mitchell K, Barreyro L, Todorova T, Taylor S, Antony Debré I, Narayanagari S, et al. IL1RAP potentiates multiple oncogenic signaling pathways in AML. J Exp Med. 2018;215:1709-1727 pubmed publisher
  13. Vitallé J, Zenarruzabeitia O, Terrén I, Plana M, Guardo A, Leal L, et al. Monocytes Phenotype and Cytokine Production in Human Immunodeficiency Virus-1 Infected Patients Receiving a Modified Vaccinia Ankara-Based HIV-1 Vaccine: Relationship to CD300 Molecules Expression. Front Immunol. 2017;8:836 pubmed publisher
  14. Zhang X, Lian X, Dai Z, Zheng H, Chen X, Zheng Y. ?3-Deletion Isoform of HLA-A11 Modulates Cytotoxicity of NK Cells: Correlations with HIV-1 Infection of Cells. J Immunol. 2017;199:2030-2042 pubmed publisher
  15. Resheq Y, Menzner A, Bosch J, Tickle J, Li K, Wilhelm A, et al. Impaired Transmigration of Myeloid-Derived Suppressor Cells across Human Sinusoidal Endothelium Is Associated with Decreased Expression of CD13. J Immunol. 2017;199:1672-1681 pubmed publisher
  16. Gorvel L, Korenfeld D, Tung T, Klechevsky E. Dendritic Cell-Derived IL-32?: A Novel Inhibitory Cytokine of NK Cell Function. J Immunol. 2017;199:1290-1300 pubmed publisher
  17. Shah F, Stepan A, O Mahony A, Velichko S, Folias A, Houle C, et al. Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators. Cell Chem Biol. 2017;24:858-869.e5 pubmed publisher
  18. Allan D, Cerdeira A, Ranjan A, Kirkham C, Aguilar O, Tanaka M, et al. Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells. Sci Rep. 2017;7:3501 pubmed publisher
  19. Yamashita Y, Anczurowski M, Nakatsugawa M, Tanaka M, Kagoya Y, Sinha A, et al. HLA-DP84Gly constitutively presents endogenous peptides generated by the class I antigen processing pathway. Nat Commun. 2017;8:15244 pubmed publisher
  20. Li R, Rezk A, Li H, Gommerman J, Prat A, Bar Or A. Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses. J Immunol. 2017;198:3245-3254 pubmed publisher
  21. Botting R, Bertram K, Baharlou H, Sandgren K, Fletcher J, Rhodes J, et al. Phenotypic and functional consequences of different isolation protocols on skin mononuclear phagocytes. J Leukoc Biol. 2017;101:1393-1403 pubmed publisher
  22. Hartwig T, Montinaro A, von Karstedt S, Sevko A, Surinova S, Chakravarthy A, et al. The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2. Mol Cell. 2017;65:730-742.e5 pubmed publisher
  23. Wouters K, Gaens K, Bijnen M, Verboven K, Jocken J, Wetzels S, et al. Circulating classical monocytes are associated with CD11c+ macrophages in human visceral adipose tissue. Sci Rep. 2017;7:42665 pubmed publisher
  24. Su S, Zou Z, Chen F, Ding N, Du J, Shao J, et al. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. Oncoimmunology. 2017;6:e1249558 pubmed publisher
  25. Raposo R, de Mulder Rougvie M, Paquin Proulx D, Brailey P, Cabido V, Zdinak P, et al. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight. 2017;2:e85811 pubmed publisher
  26. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  27. Dross S, Munson P, Kim S, Bratt D, Tunggal H, Gervassi A, et al. Kinetics of Myeloid-Derived Suppressor Cell Frequency and Function during Simian Immunodeficiency Virus Infection, Combination Antiretroviral Therapy, and Treatment Interruption. J Immunol. 2017;198:757-766 pubmed publisher
  28. Assadi G, Vesterlund L, Bonfiglio F, Mazzurana L, Cordeddu L, Schepis D, et al. Functional Analyses of the Crohn's Disease Risk Gene LACC1. PLoS ONE. 2016;11:e0168276 pubmed publisher
  29. Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, et al. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017;127:260-268 pubmed publisher
  30. Faivre V, Lukaszewicz A, Payen D. Downregulation of Blood Monocyte HLA-DR in ICU Patients Is Also Present in Bone Marrow Cells. PLoS ONE. 2016;11:e0164489 pubmed publisher
  31. Snyder Mackler N, Sanz J, Kohn J, Brinkworth J, Morrow S, Shaver A, et al. Social status alters immune regulation and response to infection in macaques. Science. 2016;354:1041-1045 pubmed
  32. Casamayor Genescà A, Pla A, Oliver Vila I, Pujals Fonts N, Marín Gallén S, Caminal M, et al. Clinical-scale expansion of CD34+ cord blood cells amplifies committed progenitors and rapid scid repopulation cells. N Biotechnol. 2017;35:19-29 pubmed publisher
  33. van Haren S, Dowling D, Foppen W, Christensen D, Andersen P, Reed S, et al. Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization. J Immunol. 2016;197:4413-4424 pubmed
  34. Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
  35. Yu Z, Zou Y, Fan J, Li C, Ma L. Notch1 is associated with the differentiation of human bone marrow?derived mesenchymal stem cells to cardiomyocytes. Mol Med Rep. 2016;14:5065-5071 pubmed publisher
  36. Nagase H, Takeoka T, Urakawa S, Morimoto Okazawa A, Kawashima A, Iwahori K, et al. ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140:686-695 pubmed publisher
  37. Byrareddy S, Arthos J, Cicala C, Villinger F, Ortiz K, Little D, et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy. Science. 2016;354:197-202 pubmed
  38. Chandele A, Sewatanon J, Gunisetty S, Singla M, Onlamoon N, Akondy R, et al. Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India. J Virol. 2016;90:11259-11278 pubmed
  39. Komdeur F, Wouters M, Workel H, Tijans A, Terwindt A, Brunekreeft K, et al. CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy. Oncotarget. 2016;7:75130-75144 pubmed publisher
  40. Gaido C, Stone S, Chopra A, Thomas W, LE SOUEF P, Hales B. Immunodominant T-Cell Epitopes in the VP1 Capsid Protein of Rhinovirus Species A and C. J Virol. 2016;90:10459-10471 pubmed publisher
  41. Di Blasio S, Wortel I, van Bladel D, de Vries L, Duiveman de Boer T, Worah K, et al. Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death. Oncoimmunology. 2016;5:e1192739 pubmed publisher
  42. Kelly A, Robinson M, Roche G, Biron C, O Farrelly C, Ryan E. Immune Cell Profiling of IFN-? Response Shows pDCs Express Highest Level of IFN-?R1 and Are Directly Responsive via the JAK-STAT Pathway. J Interferon Cytokine Res. 2016;36:671-680 pubmed
  43. Zahran A, Aly S, Altayeb H, Ali A. Circulating endothelial cells and their progenitors in acute myeloid leukemia. Oncol Lett. 2016;12:1965-1970 pubmed
  44. Zenarruzabeitia O, Vitallé J, Garcia Obregon S, Astigarraga I, Eguizabal C, Santos S, et al. The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults. Sci Rep. 2016;6:32693 pubmed publisher
  45. Ilkovitch D, Ferris L. Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules. Mol Med Rep. 2016;14:3935-40 pubmed publisher
  46. Jacoby E, Nguyen S, Fountaine T, Welp K, Gryder B, Qin H, et al. CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nat Commun. 2016;7:12320 pubmed publisher
  47. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed publisher
  48. Domingues R, de Carvalho G, Aoki V, da Silva Duarte A, Sato M. Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus. J Transl Med. 2016;14:171 pubmed publisher
  49. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed publisher
  50. Gren S, Janciauskiene S, Sandeep S, Jonigk D, Kvist P, Gerwien J, et al. The protease inhibitor cystatin C down-regulates the release of IL-? and TNF-? in lipopolysaccharide activated monocytes. J Leukoc Biol. 2016;100:811-822 pubmed
  51. Göbel K, Pankratz S, Asaridou C, Herrmann A, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626 pubmed publisher
  52. Welte T, Kim I, Tian L, Gao X, Wang H, Li J, et al. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016;18:632-44 pubmed publisher
  53. Cook A, McDonnell A, Lake R, Nowak A. Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology. 2016;5:e1066062 pubmed
  54. Qualai J, Li L, Cantero J, Tarrats A, Fernández M, Sumoy L, et al. Expression of CD11c Is Associated with Unconventional Activated T Cell Subsets with High Migratory Potential. PLoS ONE. 2016;11:e0154253 pubmed publisher
  55. Moreira M, Costa Pereira C, Alves M, Marteleto B, Ribeiro V, Peruhype Magalhães V, et al. Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes. Vet Parasitol. 2016;220:33-45 pubmed publisher
  56. Chung S, Rho S, Kim G, Kim S, Baek K, Kang M, et al. Human umbilical cord blood mononuclear cells and chorionic plate-derived mesenchymal stem cells promote axon survival in a rat model of optic nerve crush injury. Int J Mol Med. 2016;37:1170-80 pubmed publisher
  57. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  58. Leitch C, Natafji E, Yu C, Abdul Ghaffar S, Madarasingha N, Venables Z, et al. Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. J Allergy Clin Immunol. 2016;138:482-490.e7 pubmed publisher
  59. Gupta S, Termini J, Issac B, Guirado E, Stone G. Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors. PLoS ONE. 2016;11:e0148929 pubmed publisher
  60. Johnson D, Estrada M, Salgado R, Sanchez V, Doxie D, Opalenik S, et al. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy. Nat Commun. 2016;7:10582 pubmed publisher
  61. Su S, Hu B, Shao J, Shen B, Du J, Du Y, et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep. 2016;6:20070 pubmed publisher
  62. Waschbisch A, Schröder S, Schraudner D, Sammet L, Weksler B, Melms A, et al. Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System. J Immunol. 2016;196:1558-67 pubmed publisher
  63. Wang H, Feng F, Wang X, Wang R, Wu Y, Zhu M, et al. Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinoma. Mol Med Rep. 2016;13:1077-82 pubmed publisher
  64. Oliver Vila I, Coca M, Grau Vorster M, Pujals Fonts N, Caminal M, Casamayor Genescà A, et al. Evaluation of a cell-banking strategy for the production of clinical grade mesenchymal stromal cells from Wharton's jelly. Cytotherapy. 2016;18:25-35 pubmed publisher
  65. Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166 pubmed publisher
  66. Byrareddy S, Little D, Mayne A, Villinger F, Ansari A. Phenotypic and Functional Characterization of Monoclonal Antibodies with Specificity for Rhesus Macaque CD200, CD200R and Mincle. PLoS ONE. 2015;10:e0140689 pubmed publisher
  67. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  68. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed publisher
  69. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed publisher
  70. Gómez M, Qin Q, Biancardi M, Galiguis J, Dumas C, MacLean R, et al. Characterization and Multilineage Differentiation of Domestic and Black-Footed Cat Mesenchymal Stromal/Stem Cells from Abdominal and Subcutaneous Adipose Tissue. Cell Reprogram. 2015;17:376-92 pubmed publisher
  71. Monteiro Carvalho Mori da Cunha M, Zia S, Oliveira Arcolino F, Carlon M, Beckmann D, Pippi N, et al. Amniotic Fluid Derived Stem Cells with a Renal Progenitor Phenotype Inhibit Interstitial Fibrosis in Renal Ischemia and Reperfusion Injury in Rats. PLoS ONE. 2015;10:e0136145 pubmed publisher
  72. Ducret M, Fabre H, Farges J, Degoul O, Atzeni G, McGuckin C, et al. Production of Human Dental Pulp Cells with a Medicinal Manufacturing Approach. J Endod. 2015;41:1492-9 pubmed publisher
  73. Bian Y, Qian W, Li H, Zhao R, Shan W, Weng X. Pathogenesis of glucocorticoid-induced avascular necrosis: A microarray analysis of gene expression in vitro. Int J Mol Med. 2015;36:678-84 pubmed publisher
  74. Kasper J, Hermanns M, Unger R, Kirkpatrick C. A responsive human triple-culture model of the air-blood barrier: incorporation of different macrophage phenotypes. J Tissue Eng Regen Med. 2017;11:1285-1297 pubmed publisher
  75. Maass P, Aydin A, Luft F, Schächterle C, Weise A, Stricker S, et al. PDE3A mutations cause autosomal dominant hypertension with brachydactyly. Nat Genet. 2015;47:647-53 pubmed publisher
  76. Metcalf Pate K, Pohlmeyer C, Walker Sperling V, Foote J, Najarro K, Cryer C, et al. A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads. J Infect Dis. 2015;212:1387-96 pubmed publisher
  77. Skogberg G, Lundberg V, Berglund M, Gudmundsdottir J, Telemo E, Lindgren S, et al. Human thymic epithelial primary cells produce exosomes carrying tissue-restricted antigens. Immunol Cell Biol. 2015;93:727-34 pubmed publisher
  78. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed publisher
  79. Lee J, Breton G, Oliveira T, Zhou Y, Aljoufi A, PUHR S, et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med. 2015;212:385-99 pubmed publisher
  80. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed publisher
  81. Johnson P, Challis R, Chowdhury F, Gao Y, Harvey M, Geldart T, et al. Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study. Clin Cancer Res. 2015;21:1321-8 pubmed publisher
  82. Afshar M, Richards S, Mann D, Cross A, Smith G, Netzer G, et al. Acute immunomodulatory effects of binge alcohol ingestion. Alcohol. 2015;49:57-64 pubmed publisher
  83. Fytianos K, Rodríguez Lorenzo L, Clift M, Blank F, Vanhecke D, von Garnier C, et al. Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro. Nanomedicine. 2015;11:633-44 pubmed publisher
  84. Heninger A, Wentrup S, Al Saeedi M, Schiessling S, Giese T, Wartha F, et al. Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®. Immun Inflamm Dis. 2014;2:166-80 pubmed publisher
  85. Wang H, Zhang L, Zhang S, Li Y. Inhibition of vascular endothelial growth factor by small interfering RNA upregulates differentiation, maturation and function of dendritic cells. Exp Ther Med. 2015;9:120-124 pubmed
  86. Vogelpoel L, Hansen I, Rispens T, Muller F, van Capel T, Turina M, et al. Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages. Nat Commun. 2014;5:5444 pubmed publisher
  87. Thompson I, Mann E, Stokes M, English N, Knight S, Williamson D. Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection. PLoS ONE. 2014;9:e109720 pubmed publisher
  88. Milne P, Bigley V, Gunawan M, Haniffa M, Collin M. CD1c+ blood dendritic cells have Langerhans cell potential. Blood. 2015;125:470-3 pubmed publisher
  89. Fernandez C, Amarasena T, Kelleher A, Rossjohn J, McCluskey J, Godfrey D, et al. MAIT cells are depleted early but retain functional cytokine expression in HIV infection. Immunol Cell Biol. 2015;93:177-88 pubmed publisher
  90. Freeman A, Bridge J, Maruthayanar P, Overgaard N, Jung J, Simpson F, et al. Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage. PLoS ONE. 2014;9:e110928 pubmed publisher
  91. Liao S, Ding T, Rao X, Sun D, Sun P, Wang Y, et al. Cigarette smoke affects dendritic cell maturation in the small airways of patients with chronic obstructive pulmonary disease. Mol Med Rep. 2015;11:219-25 pubmed publisher
  92. O Regan N, Steinfelder S, Venugopal G, Rao G, Lucius R, Srikantam A, et al. Brugia malayi microfilariae induce a regulatory monocyte/macrophage phenotype that suppresses innate and adaptive immune responses. PLoS Negl Trop Dis. 2014;8:e3206 pubmed publisher
  93. Yu J, Zuo Z, Zhang W, Yang Q, Zhang Y, Tang Y, et al. Identification of immunophenotypic subtypes with different prognoses in extranodal natural killer/T-cell lymphoma, nasal type. Hum Pathol. 2014;45:2255-62 pubmed publisher
  94. Pritchard A, White O, Burel J, Carroll M, Phipps S, Upham J. Asthma is associated with multiple alterations in anti-viral innate signalling pathways. PLoS ONE. 2014;9:e106501 pubmed publisher
  95. Agrawal R, Wisniewski J, Yu M, Kennedy J, Platts Mills T, Heymann P, et al. Infection with human rhinovirus 16 promotes enhanced IgE responsiveness in basophils of atopic asthmatics. Clin Exp Allergy. 2014;44:1266-73 pubmed publisher
  96. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed publisher
  97. Luteijn R, Hoelen H, Kruse E, van Leeuwen W, Grootens J, Horst D, et al. Cowpox virus protein CPXV012 eludes CTLs by blocking ATP binding to TAP. J Immunol. 2014;193:1578-89 pubmed publisher
  98. Ye S, Li Z, Luo D, Huang B, Chen Y, Zhang X, et al. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget. 2014;5:5439-52 pubmed
  99. Zhang M, Ma Z, Selliah N, Weiss G, Genin A, Finkel T, et al. The impact of Nucleofection® on the activation state of primary human CD4 T cells. J Immunol Methods. 2014;408:123-31 pubmed publisher
  100. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed publisher
  101. Buggert M, Norstr m M, Salemi M, Hecht F, Karlsson A. Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progression. J Immunol. 2014;192:4685-96 pubmed publisher
  102. Brittan M, Barr L, Anderson N, Morris A, Duffin R, Marwick J, et al. Functional characterisation of human pulmonary monocyte-like cells in lipopolysaccharide-mediated acute lung inflammation. J Inflamm (Lond). 2014;11:9 pubmed publisher
  103. Hodara V, Parodi L, Chavez D, Smith L, Lanford R, Giavedoni L. Characterization of ??T cells in naïve and HIV-infected chimpanzees and their responses to T-cell activators in vitro. J Med Primatol. 2014;43:258-71 pubmed publisher
  104. Søndergaard J, Vinner L, Brix S. Natural mannosylation of HIV-1 gp120 imposes no immunoregulatory effects in primary human plasmacytoid dendritic cells. Mol Immunol. 2014;59:180-7 pubmed publisher
  105. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed publisher
  106. Narita T, Ishida T, Masaki A, Suzuki S, Ito A, Mori F, et al. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation. J Immunol. 2014;192:940-7 pubmed publisher
  107. Tan A, Hoang L, Chin D, Rasmussen E, Lopatin U, Hart S, et al. Reduction of HBV replication prolongs the early immunological response to IFN? therapy. J Hepatol. 2014;60:54-61 pubmed publisher
  108. Sölder E, Böckle B, Nguyen V, Fürhapter C, Obexer P, Erdel M, et al. Isolation and characterization of CD133+CD34+VEGFR-2+CD45- fetal endothelial cells from human term placenta. Microvasc Res. 2012;84:65-73 pubmed publisher
  109. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed publisher